'fwo types of antigen-specific T cells are needed for the elicitation of contact hypersensitivity reactions. They act in an obligate sequence to mediate the early initiating and late effector phases of contact hypersensitivity, which are accompanied by skin-swelling responses at 2 and 24 h after challenge, respectively. The magnitude of the late ear swelling depends on that of the early swelling.
late phases of contact hypersensitivity were largely suppressed in ultraviolet-irradiated, actively sensitized mice. Transfer of immune lymphoid cells from donor mice that were sensitized 4 d earlier induced early and late components of contact hypersensitivity in naive recipients after challenge. Transfer of immune lymphoid cells from donors that were sensitized 1 d earlier only induced the early component of cO. ntact. hZ'persensitivity. Ultraviolet i~radiation of donor mIce sIgl1lficantiy reduced the capacIty of the immune lymphoid cells to induce contact hypersensitivity. We show that lymphoid cells responsible for the early and late components of contact hypersensitivity are both affected. Key words:
ultraviolet radiatiDrl/CHS/mice/photoimmunology. ] Invest DermatoI102:923-927,1994
Thy-I+, CDS+, CD4-, CDS-, CD3-, CD4SRA+, and expresses 1L-3 receptors but no 1L-2 receptors. On the other hand, the classical, late DTH effector T cell is Thy-1+, CDS+, CD4+, CDS-, CD3+, CD4SRA-, and expresses 1L-2 receptors but no 1L-3 receptors. After sensitization, the DTH-initiating T cells in lymphoid organsyroduce an antigen-specific factor that can subsectuently be found m the circulation as early as 1 d after sensitization lI7]. This factor sensitizes the extravascular tissues such as the skin [IS] . Elicitation of DTH with specific antigen leads initially to an immediate hypersensitivity-like early reaction that is due to local release of the vasoactive amine serotonin by mast cells [IS] and possibly by other cells [~9~2. 0] . . These cells are sensitized with this antigen-specific DTH-uutlatmg factor that is analogous to 19E antibodies [13, 21, 22] . Serotonin renders the vascular endothelium locally permeable [23, 24] , allowing late-acting antigen/major histocompatibility complex -restricted T cells to enter the site. Histologic proof for this ea rly swelling reaction was provided by Kops et af [24] .
Serotonin also activates the recruited late-acting T cells through specific serotonin-2 receptors [25] . These recruited classical DTH T cells are activated by binding of ex: P T-cell receptors to antigen/ major histocompatibility complexes on local antigen presenting ~ells and produce lymphokines that attract the 24-h perivascular mfiltrate of nonspecific inflammatory cells. For humans similar mechanisms are suggested [26] .
The purpose of the present investigation was firstly, to examine whether UVR, besides suppressing the late 24-h swelling reaction, also suppresses the early 2-h swelling reaction of the contact hypersensitivity reaction (CHS) to Picryl Chloride (PCl) ; and secondly, 0022-202Xj94jS07.00 Copyright © 1994 by The Sociery for Investigative Dermatology, Inc.
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because the early initiating phase ofDTH facilitates the full expression of the late effector phase of DTH [12, 27] , to investigate whether impairment of the late effector phase was in fact due to an effect of UVR on the early initiating phase.
MATERIALS AND METHODS
Mice DBA/2 mice (8-12 weeks old, male) were obtained from Harlan, UK. Mice were rested at least 2 weeks before use and were housed in macro lon cages with unlimited access to standard mouse chow and tap water.
General Reagents PCl (Chemotronix, Swannanoa, NC) was recrystallized three times from methanol/H 2 0 before use, and protected from light during storage at 4 0 C. Measurement of Contact Hypersensitivity (CHS) Ear-Swelling Responses Four days after sensitization, both ears of the mice were challenged by topical application of one drop (27-gauge need le) of 0.8% PCl in olive oil. Prior to challenge and at various times thereafter (2, 4, 24, and 48 h) duplicate m~asurements of ear thickness were made using an engineer's micrometer (Mitutoyo digimatic 293561). In each experiment, the increase in ear thickness in similarly challenged, nonsensitized, control mice was measured at the same time, and subtracted from increments in ear thickness in sensitized test animals. The data were expressed in 10-3 cm ± SEM.
UVR
Adoptive Transfer of Lymphoid Cells (Passive Sensitization) Suspensions oflymphoid cells pooled from the axillar and inguinal lymph nodes and the spleen were prepared from mice that were UV -irradiated and sensitized to PCl as described before. Cell suspensions were made by gently pressing the lymph nodes and spleens through a stainless steel screen. The cell suspensions were washed three times in phosphate-buffered saline. Subsequently, cell counts were performed and viability was checked by trypan blue exclusion. Generally, viability was higher than 90%. 5 X 10 7 lymphoid cells in 0.3 ml PBS were transferred into the retroorbital plexus of normal recipient mice under light ether anesthesia. These recipients were challenged 1 d later, as indicated above.
Statistics Levels of significance were calculated using the Student t test; p < 0.05 was taken as a significant difference between groups.
RESULTS
Effect ofUV Irradiation on the Early and Late Swelling Reactions of the CHS Reaction to PCI To determine the effect of UVR on the early and late swelling reactions of the CHS response to PCl, we irradiated mice on four consecutive days and actively sensitized them to PCI 4 d after the last irradiation on the non -UVirradiated skin. Four days after sensitization, mice were challenged with PCI on the ears, and ear swelling was measured at certain intervals after challenge. In non-UV-irradiated control animals, the early swelling response at 2 h was accompanied by a noticeable swelling and redness of the ears . In duplicate experiments, the 2-h ear-swelling response, which represents the early component of the CHS response, was significantly and almost completely inhibited in UV-irradiated sensitized animals (UV) as compared to the non-irradiated sensitized controls (NR) . At 4 h after challenge, the swelling reactions in both groups were not significant. The 24-h ear-swelling response, which represents the late component of the CHS response, was also greatly reduced in UV -irradiated, sensitized animals as compared to the non-irradiated, sensitized controls (Fig 1) . [14] . These cells release a PCI-specific T-cell factor and are induced within 1 d of sensitization [17] . Transfer oflymphoid cells from actively sensitized non-irradiated donors 1 d after sensitization (day one immune lymphoid cells) results in transfer of the 2-h component of CHS (Fig 2a, panel B) , but not of the 24-h component of CHS (Fig 2b,  panel B Time (h) (Fig 2a, panel A) . However, the reduction of the 24-h swelling reaction by UV irradiation of the PCl sensitized donor mice (Fig 2b, panel C) was not abolished by addition of day 1 im~une lymphoid c~lls to the day 4 UV-immune lymphoid cells (Fig 2b, pallel D) . ThiS shows that the UV-mduced reduction of the 24-h ear-swelling response is not solely due to the reduction of the 2-h ear-swelling response. If impairment of the early initiating phase is the primary effect ofuVR on CHS, then reconstitution of the 2-h response should have resulted in reconstitution of the 24-h response as well.
DISCUSSION
In these studies the systemic effects of low-dose UVR on the early initiating phase and the late effector phase of CHS reactions to PCl were investigated. The UV-irradiation protocol that was used suppressed both the early and the late c?mponents in a~tively sensitized mice as well as prevented the adoptive transfer of either component with lymphoid cells from the irradiated, sensitized donors. The early, initiating phase of CHS, which is mediated by an antigen-UVR-INDUCED IMPAIRMENT OF CHS 925 specific T-cell factor, facilitates the full expression of the late effector phase of CHS [12, 17] . UVR-induced impairment of the early , initiating phase could therefore result in a reduced expression of the late effector phase. In other words, the UVR-induced impairment of the late effector phase could be an indirect effect ofUVR. To test this hypothesis, we co-transferred lymphoid cells from UVR-exposed donor mice that were sensitized 4 d earlier together with lymphoid cells taken from non-irradiated animals 1 dafter PCl sensitization. The latter cells are known to transfer only the early initiating phase of CHS. Transfer of immune lymphoid cells from UVR-exposed donor mice that were sensitized 4 d earlier resulted in the absence of the early swelling and a weak late swelling response after challenge of the recipients. Addition of day 1 immune lymphoid cells from PCI-sensitized, non-irradiated animals to day 4 immune lymphoid cells from UV-irradiated, PCL-sensitized animals reconstituted the early ear-swelling response, but failed to re-establish the late swelling response. If the UVR-induced impairment of the late ear-swelling response was in fact due to a red.uction of the early response, reconstitution of the early response ("preparing the way") should have resulted in reconstitution of the late ear-swelling response. That this did not occur indicates that UVR-induced impairment of both phases is regulated by two different mechanisms.
From earlier studies it was already known that UVR could impair the late effector phase in DTH in both local and systemic ways. Work by several investigators has shown that the UVR-induced immunosuppression of CHS is associated with the appearance of UVR-induced antigen-specific suppressor T lymphocytes [29] . These UVR-induced suppressor T lymphocytes produce haptenspecific suppressor factor(s} il1l1itro that inhibit CHS response il111i1l0 [30] .
Several possible mechanisms have been suggested to explain UVR-induced activation of suppressor T cells. Direct action of UVR on photoreceptors in the skin such as DNA [31 ,32] al [38] that is possibly identical to factors described by Swartz [39] and Molendijk. t Tumor necrosis factor-a is probably one of the most important products released by keratinocytes after UVR exposure and may be responsible for UVR-induced suppression of CHS by affecting the activiry of Langerhans cells [40] . The susceptibiliry for UVR-induced immunosuppression appears to be genetically determined. The lipopolysaccharide locus in mice correlates very well with UVR susceptibiliry trait. Moreover tumor necrosis factor-a, a cytokine produced extensively by mice that possess the lipopolysaccharide allele, appears to mediate UVR-induced suppression of the cellular immune system. Intradermal injection of tumor necrosis fac~or-a.a~ the site~ of hapten application mimics th~ effects ofUYR by Impamng the tnduction of CHS. Another pOSSIble mecharusm leading to UVR-induced suppression of CHS may be the altered expression of co-stimulatory molecules such as intercellular adhe- with the findings of Simon et al [45] , who showed that UVRindu~es a long-lasting anergy of Th 1 cells, but not of Th2 cells, which results from a lack in their ability to produce interleukin-2.
The different mechanisms ofUVR-induced immunosuppression are recently reviewed by Goettsch et al [46] . The precise modes of action of the skin-derived UVR-induced substances are still unclear, as is the mechanism by which the UVR-induced suppressor T cells are activated.
The mechanisms described only account for the suppression of the late effector phase of DTH reactions. In the present study, evidence is provided that the early initiating phase of CHS is also impaired by UVR. Moreover, this impairment of the early initiating phase seems to be regulated by another mechanism than the impairment of the late effector phase of CHS.
From earlier studies it is known that the expression of the early initiating phase of CHS is dependent on the production of an antigen-specific T-cell factor [17] . The production of this factor is regulated by a feedback mechanism. The factor induces T cells with a suppressor function to produce non -antigen-specific suppressor factors that suppress the T cells that are responsible for production of the DTH-initiating, antigen-specific T-cell factors [47, 48] . Therefore, the factor suppresses indirectly the initiation of DTH responses to contact sensitizers, sheep erythrocytes, and allogeneic tumor cells [47 -49] in a non-antigen-specific manner. It might well be possible that UVR induces the production of an UVR-specific factor that impairs the initiation of the immune response to PCI. However, there is no evidence (yet) for the presence of an UVR-specific factor. Whether tumor necrosis factor-a or other cytokines that can inhibit CHS are also involved in the suppression of the early phase reaction is not known. Adhesion molecules such as intercellular adhesion molecule-I, which are necessary for the migration of cells into the epidermis, are thought to be involved in UVR-induced immunosupression [50] . The early swelling reaction is not due to cellular infiltrate [24] but due to an increased vascular permeability, i.e., an edematous swelling reaction. For this reason a role for adhesion molecules alterations due to UVB exposure in the suppression of the early swelling reaction is not likely.
A possible mechanism by which UVR could impair both early and late phases of the CHS response to PCI lies in the observation that both early and late phases of DTH can be reduced by systemic administration of transforming growth factor-PI at the time of antigen challenge [51] . UV irradiation of murine skin might result in a systemic increase in the release of transforming growth factor-PI, thus mimicking the effect of systemic administration. However, although it is demonstrated that the levels of various epidermal cytokines are increased after UV irradiation (reviewed in [52] ), it has not (yet) been reported that transforming growth factor-PI release is increased by UVR exposure.
